Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-05-13Clinical Trial Update: Natural History of Coronary Heart Disease
The document notes the completion of a National Heart, Lung, and Blood Institute study on the natural history of coronary heart disease. It …
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Stroke Risk in the NAS-NRC Twin Registry
This completed NHLBI study update reports on stroke risk and other cardiovascular outcomes in the NAS-NRC Twin Registry.
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Protein S and Myocardial Infarction
Clinical trial update indicates a completed trial evaluating protein S in relation to myocardial infarction. No results are provided in the …
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Survival After Myocardial Infarction in A Biethnic Texas Community (Corpus Christi Heart Project)
A completed NHLBI study evaluating survival after myocardial infarction in a biethnic community in Corpus Christi, Texas. The observational …
-
CLINICAL_TRIALS research · 2016-05-12Clinical Trial Update: Aspirin Response in High Risk Patients With Coronary Artery Disease
This document provides an update on a clinical trial evaluating aspirin response in high-risk patients with coronary artery disease; it list…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-05-11FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Inc)
The FDA approved a supplemental application filed by Dr. Reddy's Laboratories Inc for clopidogrel bisulfate (generic) to support changes to …
-
FDA approval · 2016-05-11FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for CLOPIDOGREL BISULFATE submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2016-05-10FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (RADHA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for clopidogrel bisulfate (generic clopidogrel) from Radha Pharmaceuticals, Inc., indicating approva…
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Implication of Left veNtricle Vortex Flow Guided aNticOagulation Therapy for preVenting Apical Thrombus Formation In Patients With Acute myOcardial infarctioN: Multicenter Prospective Randomized Clinical Trial; INNOVATION Study
A multicenter randomized trial (INNOVATION) evaluated whether left ventricular vortex flow-guided anticoagulation could prevent apical throm…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Omacor Plus Standard Therapies In Post Myocardial Infarction (MI) Subjects Evaluation: The OPTIMISE Observational Study
Observational study update evaluating Omacor Plus standard therapies in post-myocardial infarction patients; study completed with posted res…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Cardiac Arrhythmia Suppression Trial (CAST) [Phase 3]
The CAST trial, a Phase 3 cardiac arrhythmia study, has completed.
-
CLINICAL_TRIALS research · 2016-05-06Clinical Trial Update: Mindful Movement Intervention for Post-MI Patients [NA]
This document reports a clinical trial evaluating a mindful movement intervention for patients after myocardial infarction, sponsored by the…
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Myocardial Infarction Genes (MI-GENES) Study [NA]
The MI-GENES study conducted by Mayo Clinic is a completed clinical trial evaluating genomic risk communication in patients with coronary ar…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Home-based Cardiovascular Rehabilitation, Maintenance Phase, in Subjects With Coronary Artery Disease [NA]
The trial update indicates completion of a maintenance-phase, home-based cardiovascular rehabilitation study in patients with coronary arter…
-
FDA approval · 2016-04-26FDA Approved: CARVEDILOL — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for carvedilol filed by Advagen Pharma Ltd, resulting in an additional authorization for the product…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE) [Phase 3]
Phase 3 PEACE trial evaluated whether ACE inhibitor therapy with trandolapril reduces cardiovascular events in patients with stable coronary…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients [Phase 3]
Clinical trial update for the Phase 3 ENRICHD study assessing recovery in coronary heart disease; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Public Access Defibrillation (PAD) Community Trial [Phase 3]
Phase 3 clinical trial on public access defibrillation (PAD) in community settings has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Honolulu Heart Program
Update on the Honolulu Heart Program, a completed clinical trial focused on cardiovascular diseases and related conditions.
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Magnesium in Coronaries (MAGIC) [Phase 3]
The MAGIC Phase 3 trial evaluating magnesium in coronary disease has completed; the document notes the status but does not provide trial res…
-
FDA approval · 2016-04-12FDA Approved: ENALAPRIL MALEATE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for enalapril maleate from ScieGen Pharmaceuticals, Inc. (ANDA 075178).
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Clinical Trial to Assess the Safety of Reducing the Time of Bed Rest After Cardiac Catheterization [NA]
The document reports the completion of a clinical trial assessing the safety of reducing bed-rest time after cardiac catheterization, sponso…
-
CLINICAL_TRIALS research · 2016-04-12Clinical Trial Update: The Brain Heart Interaction in Acute Stroke
This Clinical Trial Update reports on a completed study investigating brain–heart interactions in acute stroke (NCT02734082). The study invo…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects
The trial assesses the optimal cut-off value of PEA measured by the Corsens Device to distinguish myocardial infarction from non-MI subjects…
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Aspirin-Myocardial Infarction Study (AMIS) [Phase 3]
The Phase 3 Aspirin-Myocardial Infarction Study (AMIS) has completed. It was sponsored by the National Heart, Lung, and Blood Institute (NHL…